Skip to main content
Premium Trial:

Request an Annual Quote

Agena Bioscience Partners With N-of-One on MassArray Data Interpretation

NEW YORK (GenomeWeb) – N-of-One has entered into a partnership to help Agena Bioscience interpret cancer genomic data generated by its MassArray system, the companies announced today.

Agena's MassArray is a research-use-only platform designed to detect genetic variation with end-point PCR and label-free mass spectrometry. The deal with N-of-One is designed to support the expansion of MassArray Insights, a recently launched reporting network through which Agena seeks to collaborate with various molecular analysis platform providers.

"MassArray Insights is part of Agena Bioscience's continued effort to support our CLIA-high complexity certified lab customers who are tackling the challenges presented in molecular diagnostics," Agena CEO Pete Dansky said in a statement. "We are happy to partner with ... N-of-One to help bring our lab clients an important component that nicely follows the value of our test: an evidence-based, clinically actionable report."

Specific terms of the deal were not disclosed.

In September, Agena signed on Molecular Health as the first interpretation software provider for MassArray Insights.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.